Home LiteratureArticle Details
PMID: 2407652 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Synthesis and immunological properties of conjugates composed of group B streptococcus type III capsular polysaccharide covalently bound to tetanus toxoid.

Infection and immunity ·Vol. 58 ·No. 3 ·1990-03-00 ·Pages 687-94

Lagergard T, Shiloach J, Robbins JB, Schneerson R

Abstract

A synthetic scheme for covalently binding group B streptococcus type III to tetanus toxoid (TT), using adipic acid dihydrazide as a spacer, is described. Type III alone or as a conjugate with TT was injected subcutaneously into laboratory mice, and the type-specific and TT antibody responses elicited by these immunogens were assayed. Type III-TT elicited significantly higher levels of type-specific antibodies after each immunization than did the type III alone. These levels were related to the dosage of the conjugate, enhanced by Freund adjuvant, and exhibited booster responses. Type III alone elicited only immunoglobulin M (IgM) antibodies in Swiss albino mice and mostly IgM and low levels of IgG antibodies of the IgG3 subclass in BALB/c mice. Type III-TT conjugates, in contrast, elicited mostly IgG antibodies in both strains of mice. IgA type III antibodies were not detected. The first two immunizations with the conjugates elicited type III antibodies in the IgG1 and in the IgG3 subclasses. Low levels of IgG2a type III antibodies were detected after a third injection of type III-TT. Conjugate-induced antibodies facilitated opsonization of group B streptococcus type III organisms and did not react with the structurally related pneumococcus type 14. TT alone or as a component of type III-TT induced mostly antibodies of the IgG class: IgG1 levels were the highest of the four subclasses. No IgA TT antibodies were detected. The conjugation procedure, therefore, enhanced the immunogenicity of and conferred T-cell dependent properties to the type III while preserving the immunogenicity of the TT component. The T-cell dependent properties of the conjugates were responsible for stimulating IgG type III antibodies which could be boosted. Evaluation of type III-TT conjugates in antibody-negative women of child-bearing age is planned.

MeSH Terms
Animals Antigens, Bacterial/analysis Bacterial Toxins/immunology Immunization Immunoglobulin G/analysis,classification Immunoglobulin M/analysis Mice Mice, Inbred BALB C Phagocytosis Polysaccharides, Bacterial/immunology Streptococcus agalactiae/immunology Tetanus Toxoid/immunology
Chemicals
Antigens, Bacterial Bacterial Toxins Immunoglobulin G Immunoglobulin M Polysaccharides, Bacterial Tetanus Toxoid streptococcal polysaccharide type III group B
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Lagergard T
National Institute of Child Health and Human Development, Bethesda, Maryland 20892.
Shiloach J
Robbins J B
Schneerson R
References (52)
52 references, click to expand
  1. Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates.
    Infect Immun. 1986 May;52(2):519-28 PMID: 3516876
  2. Group B streptococcal carriage and disease: a 6-year prospective study.
    J Pediatr. 1987 Jan;110(1):31-6 PMID: 3540249
  3. Group B streptococcal neonatal and infant infections.
    J Pediatr. 1973 Apr;82(4):707-18 PMID: 4572747
  4. Structure of native polysaccharide antigens of type Ia and type Ib group B Streptococcus.
    Biochemistry. 1983 Mar 1;22(5):1258-64 PMID: 6838851
  5. Isolation and characterization of type IV group B Streptococcus capsular polysaccharide.
    Infect Immun. 1989 Apr;57(4):1089-94 PMID: 2494110
  6. Structural determination of the capsular polysaccharide antigen of type II group B Streptococcus.
    J Biol Chem. 1983 Feb 10;258(3):1793-8 PMID: 6337145
  7. Further studies on the immunogenicity of Haemophilus influenzae type b and pneumococcal type 6A polysaccharide-protein conjugates.
    Infect Immun. 1983 Apr;40(1):245-56 PMID: 6601061
  8. Opsonic specificity of human antibody to the type III polysaccharide of group B Streptococcus.
    J Infect Dis. 1979 Dec;140(6):1004-8 PMID: 396335
  9. Suppurative meningitis due to streptococci of Lancefield group B: a study of 33 infants.
    J Pediatr. 1973 Apr;82(4):724-9 PMID: 4735411
  10. Conformational aspects critical to the immunospecificity of the type III group B streptococcal polysaccharide.
    Biochemistry. 1981 Aug 4;20(16):4511-8 PMID: 6170311
  11. Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy.
    N Engl J Med. 1987 Sep 17;317(12):717-22 PMID: 3306379
  12. Immunodeterminant specificity of human immunity to type III group B streptococcus.
    J Exp Med. 1979 Feb 1;149(2):327-39 PMID: 84042
  13. Group B beta-hemolytic streptococci and puerperal infections.
    Am J Obstet Gynecol. 1981 Mar 15;139(6):686-9 PMID: 7011033
  14. Association of type- and group-specific antigens with the cell wall of serotype III group B streptococcus.
    Infect Immun. 1982 Jun;36(3):1115-22 PMID: 7047392
  15. Soluble group- and type-specific antigens from type III group B Streptococcus.
    Infect Immun. 1980 Apr;28(1):195-203 PMID: 6155346
  16. Neonatal septicemia in Stockholm.
    Eur J Clin Microbiol. 1987 Jun;6(3):262-5 PMID: 3305005
  17. Demonstration of opsonic activity and in vivo protection against group B streptococci type III by Streptococcus pneumoniae type 14 antisera.
    J Exp Med. 1978 Sep 1;148(3):776-86 PMID: 29937
  18. Isolation of type-specific polysaccharide antigen from group B type Ib streptococci.
    J Exp Med. 1979 Jan 1;149(1):58-66 PMID: 33225
  19. A SEROLOGICAL DIFFERENTIATION OF HUMAN AND OTHER GROUPS OF HEMOLYTIC STREPTOCOCCI.
    J Exp Med. 1933 Mar 31;57(4):571-95 PMID: 19870148
  20. An avidin-biotin based ELISA for quantitation of antibody to bacterial polysaccharides.
    J Immunol Methods. 1985 Oct 10;82(2):215-24 PMID: 3900215
  21. Antibody to group B Streptococcus type III in human sera measured by a mouse protection test.
    Infect Immun. 1981 Apr;32(1):56-61 PMID: 7216494
  22. CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS : IV. THE SYNTHESIS OF THEp-AMINOBENZYL ETHER OF THE SOLUBLE SPECIFIC SUBSTANCE OF TYPE III PNEUMOCOCCUS AND ITS COUPLING WITH PROTEIN.
    J Exp Med. 1931 Jul 31;54(3):431-6 PMID: 19869929
  23. Class specificity of naturally acquired and vaccine-induced antibody to type III group B streptococcal capsular polysaccharide: determination with a radioimmunoprecipitin assay.
    Infect Immun. 1984 May;44(2):257-61 PMID: 6370863
  24. Studies on yeast metabolism. I. Fractionation and microdetermination of cell carbohydrates.
    Biochem J. 1952 Jan;50(3):298-303 PMID: 14915949
  25. ANTIGENIC RELATIONSHIPS BETWEEN GROUPS B AND G STREPTOCOCCI.
    J Exp Med. 1964 Oct 1;120:629-37 PMID: 14212124
  26. A SEROLOGICAL DIFFERENTIATION OF SPECIFIC TYPES OF BOVINE HEMOLYTIC STREPTOCOCCI (GROUP B).
    J Exp Med. 1934 Mar 31;59(4):441-58 PMID: 19870257
  27. Structure and immunochemistry of an oligosaccharide repeating unit of the capsular polysaccharide of type III group B Streptococcus. A revised structure for the type III group B streptococcal polysaccharide antigen.
    J Biol Chem. 1987 Jun 15;262(17):8262-7 PMID: 3298228
  28. The role of IL-5 in IgA B cell differentiation.
    J Immunol. 1988 May 1;140(9):3033-9 PMID: 3258891
  29. Protective levels of serum antibodies stimulated in infants by two injections of Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugate.
    J Pediatr. 1989 Jan;114(1):97-100 PMID: 2783345
  30. Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates.
    J Exp Med. 1980 Aug 1;152(2):361-76 PMID: 6967514
  31. The presence of sialic acid on two related bacterial polysaccharides determines the site of the primary immune response and the effect of complement depletion on the response in mice.
    J Immunol. 1982 Jun;128(6):2731-3 PMID: 7042846
  32. Structure and serology of the native polysaccharide antigen of type Ia group B streptococcus.
    Proc Natl Acad Sci U S A. 1980 May;77(5):2931-5 PMID: 6156459
  33. Quantitative determination in human sera of vaccine-induced antibody to type-specific polysaccharides of group B streptococci using an enzyme-linked immunosorbent assay.
    J Infect Dis. 1983 May;147(5):847-56 PMID: 6341484
  34. Immunogenicity of polysaccharides from type III, group B Streptococcus.
    J Clin Invest. 1978 Apr;61(4):1107-10 PMID: 96132
  35. Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus.
    N Engl J Med. 1988 Nov 3;319(18):1180-5 PMID: 3050524
  36. Group B streptococcal infections.
    Adv Intern Med. 1980;25:475-501 PMID: 6153860
  37. NEONATAL SEPSIS AND OTHER INFECTIONS DUE TO GROUP B BETA-HEMOLYTIC STREPTOCOCCI.
    N Engl J Med. 1964 Dec 10;271:1221-8 PMID: 14234266
  38. CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS : V. THE IMMUNOLOGICAL SPECIFITY OF AN ANTIGEN PREPARED BY COMBINING THE CAPSULAR POLYSACCHARIDE OF TYPE III PNEUMOCOCCUS WITH FOREIGN PROTEIN.
    J Exp Med. 1931 Jul 31;54(3):437-47 PMID: 19869930
  39. Group B, type III streptococcal cell wall: composition and structural aspects revealed through endo-N-acetylmuramidase-catalyzed hydrolysis.
    Infect Immun. 1982 Feb;35(2):572-81 PMID: 7035367
  40. THE SEROLOGICAL DIFFERENTIATION OF PATHOGENIC AND NON-PATHOGENIC STRAINS OF HEMOLYTIC STREPTOCOCCI FROM PARTURIENT WOMEN.
    J Exp Med. 1935 Feb 28;61(3):335-49 PMID: 19870362
  41. Group B beta hemolytic streptococcal meningitis in infants.
    J Pediatr. 1973 Apr;82(4):719-23 PMID: 4572748
  42. A submicrodetermination of glucose.
    J Biol Chem. 1949 Nov;181(1):149-51 PMID: 15390401
  43. Antigenic specificity of opsonophagocytic antibodies in rabbit anti-sera to group B streptococci.
    J Immunol. 1977 Feb;118(2):673-8 PMID: 65433
  44. Quantitation of in vitro opsonic activity of human antibody induced by a vaccine consisting of the type III-specific polysaccharide of group B streptococcus.
    Infect Immun. 1983 Mar;39(3):1155-60 PMID: 6341229
  45. Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens.
    J Exp Med. 1975 Jul 1;142(1):165-79 PMID: 1097573
  46. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection.
    N Engl J Med. 1976 Apr 1;294(14):753-6 PMID: 768760
  47. Subclass restriction of murine anti-carbohydrate antibodies.
    J Immunol. 1978 Aug;121(2):566-72 PMID: 79606
  48. Target antigens for bactericidal and opsonizing antibodies to Haemophilus influenzae.
    Acta Pathol Microbiol Immunol Scand C. 1982 Aug;90(4):209-16 PMID: 6982592
  49. Detection of neutral and aminosugars from glycoproteins and polysaccharides as their alditol acetates.
    J Chromatogr. 1983 Feb 18;256(3):419-27 PMID: 6841516
  50. A radioimmunoassay for immunologic phenomena in pneumococcal disease and for the antibody response to pneumococcal vaccines. I. Method for the radioimmunoassay of anticapsular antibodies and comparison with other techniques.
    J Immunol Methods. 1980;33(2):133-44 PMID: 6154745
  51. The clinical significance of group B streptococci.
    J Perinat Med. 1982;10(3):133-46 PMID: 7050338
  52. The derivatization of cross-linked polyacrylamide beads. Controlled introduction of functional groups for the preparation of special-purpose, biochemical adsorbents.
    Biochemistry. 1969 Oct;8(10):4074-82 PMID: 5388146
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1990-03-00
Pages
687-94
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC258520
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]